{"id":"remimazolam-tosilate-for-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Injection site pain"}]},"_chembl":{"chemblId":"CHEMBL4297526","moleculeType":"Small molecule","molecularWeight":"439.31"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Remimazolam tosilate is a rapid-onset, short-acting benzodiazepine agonist at GABA-A receptors in the central nervous system. It potentiates inhibitory GABAergic signaling, leading to sedative, anxiolytic, and muscle-relaxant effects. The drug is rapidly metabolized by tissue esterases, resulting in a shorter duration of action compared to traditional benzodiazepines.","oneSentence":"Remimazolam is a benzodiazepine that enhances GABAergic neurotransmission by binding to GABA-A receptors, producing sedation and anxiolysis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:04:40.709Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Procedural sedation and anesthesia induction"},{"name":"Sedation in intensive care units"}]},"trialDetails":[{"nctId":"NCT07036419","phase":"PHASE2, PHASE3","title":"A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-07-10","conditions":"Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients","enrollment":240},{"nctId":"NCT06222294","phase":"PHASE3","title":"A Study of Remimazolam Tosilate for Sedation in the ICU","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-03-12","conditions":"Sedation in the ICU","enrollment":214},{"nctId":"NCT05549791","phase":"","title":"A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2022-08-18","conditions":"General Anesthesia and Bronchoscopy Sedation","enrollment":1285},{"nctId":"NCT05254366","phase":"","title":"A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2022-01-30","conditions":"Gastroscopic and Colonoscopic Sedation","enrollment":2022},{"nctId":"NCT05913336","phase":"PHASE1, PHASE2","title":"A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2023-06-27","conditions":"Sedation in the ICU","enrollment":24},{"nctId":"NCT04908553","phase":"PHASE4","title":"Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults","status":"COMPLETED","sponsor":"Tongji Hospital","startDate":"2021-07-01","conditions":"Hypotension During Surgery","enrollment":650},{"nctId":"NCT06216444","phase":"PHASE4","title":"A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-01","conditions":"Sedation in Non-intubated Diagnostic and Therapeutic Procedures","enrollment":240},{"nctId":"NCT06169995","phase":"PHASE4","title":"A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2023-12-11","conditions":"Sedation in the Upper Gastrointestinal Endoscopy","enrollment":31},{"nctId":"NCT05152303","phase":"PHASE2","title":"A Study of Remimazolam Tosilate for Sedation in the ICU","status":"COMPLETED","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2022-10-12","conditions":"Sedation in the ICU","enrollment":60},{"nctId":"NCT05631028","phase":"NA","title":"95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment","status":"COMPLETED","sponsor":"Shiyou Wei","startDate":"2022-12-01","conditions":"Lung Cancer, Anesthesia Induction","enrollment":115},{"nctId":"NCT04400201","phase":"PHASE3","title":"A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2020-06-15","conditions":"Sedation","enrollment":330},{"nctId":"NCT05480787","phase":"PHASE4","title":"Pharmacokinetic Study of Continuous Infusion of Remazolam in Mechanically Ventilated Patients in ICU","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-02-01","conditions":"Intensive Care Unit, Mechanical Ventilation, Anesthesia","enrollment":30},{"nctId":"NCT05015361","phase":"PHASE2","title":"A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-05-07","conditions":"Local Anesthesia Assisted Sedation","enrollment":108}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"SHOCK"}],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Remimazolam Tosilate for Injection","genericName":"Remimazolam Tosilate for Injection","companyName":"Jiangsu HengRui Medicine Co., Ltd.","companyId":"jiangsu-hengrui-medicine-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Remimazolam is a benzodiazepine that enhances GABAergic neurotransmission by binding to GABA-A receptors, producing sedation and anxiolysis. Used for Procedural sedation and anesthesia induction, Sedation in intensive care units.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}